Kidney Cancer Coverage From Every Angle
Advertisement
Advertisement

Thomas Powles, MD, on Urothelial Carcinoma: Results From the IMvigor211 Trial

Posted: Monday, February 12, 2018

Thomas Powles, MD, of Barts Cancer Institute, discusses phase III study findings on atezolizumab vs chemotherapy in platinum-treated locally advanced or metastatic urothelial carcinoma, in light of the NCCN Guidelines.